Area of research
Immunology · Dermatology
Research interest
Research interests include Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Spondyloarthritis Studies and Treatments, and Health Systems, Economic Evaluations, Quality of Life.
Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review
A Review of Phase <scp>III</scp> and Long‐Term Data for Deucravacitinib for Plaque Psoriasis
Review of category A bioweapons with cutaneous features: Epidemiology, clinical presentation, and contemporary management strategies
Sex Disparities of Health-related Quality of Life in Moderate to Severe Psoriasis: A Real-world Analysis from the Swiss Psoriasis Registry (SDNTT)
Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis
Full Guidelines—From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis
Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study
1323P RATIONALE-307 long-term outcomes: First-line tislelizumab (TIS) plus chemotherapy (chemo) vs chemo alone for advanced squamous (sq) NSCLC
Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States
Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies
Access to psoriasis treatment in Brazil and Chile: A cross-sectional multicentre Global Healthcare Study on Psoriasis
Association between electronic-cigarette use and atopic dermatitis among United States adults
Association of people with atopic dermatitis and household income among <scp>US</scp> adults in the 1999–2006 National Health and Nutrition Examination Survey
It is time to consider a new topical algorithm for psoriasis
41279 Real-World Switch Rates of Biologics and Associated Costs in Patients With Psoriasis
100 Rapid and sustained improvement in sleep quality, anxiety, and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment
Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
Economic Burden of Comorbidities in Patients with Psoriasis in the USA
The association between atopic dermatitis, cognitive function and school performance in children and young adults
Association between atopic dermatitis and thyroid disease among U.S. adults in the 2001-2006 National Health and Nutrition Examination Survey
The risk of COVID-19 in patients with psoriasis: A retrospective cohort study
Clinical Efficacy and Safety of Psoriasis Treatments in Patients with Concomitant Metabolic Syndrome: A Narrative Review
Atopic dermatitis on TikTok™: a cross-sectional study
Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis
Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies
Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures
Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS
Risk of tuberculosis reactivation during interleukin‐17 inhibitor therapy for psoriasis: a systematic review
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics